2op3: Difference between revisions

Revision as of 03:03, 29 July 2008

This article has been automatically seeded. Changes to this page should pertain to the PDB entry only and not to the protein or biomolecule in general.

File:2op3.png

Template:STRUCTURE 2op3

The structure of cathepsin S with a novel 2-arylphenoxyacetaldehyde inhibitor derived by the Substrate Activity Screening (SAS) methodThe structure of cathepsin S with a novel 2-arylphenoxyacetaldehyde inhibitor derived by the Substrate Activity Screening (SAS) method

Template:ABSTRACT PUBMED 17469812

About this StructureAbout this Structure

2OP3 is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.

ReferenceReference

Characterization and optimization of selective, nonpeptidic inhibitors of cathepsin S with an unprecedented binding mode., Inagaki H, Tsuruoka H, Hornsby M, Lesley SA, Spraggon G, Ellman JA, J Med Chem. 2007 May 31;50(11):2693-9. Epub 2007 May 1. PMID:17469812

Page seeded by OCA on Tue Jul 29 03:03:21 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA

@@ Line 1: / Line 1: @@
-[[Image:2op3.jpg|left|200px]]
+{{Seed}}
+[[Image:2op3.png|left|200px]]
 <!--
@@ Line 9: / Line 10: @@
 {{STRUCTURE_2op3|  PDB=2op3  |  SCENE=  }}
-'''The structure of cathepsin S with a novel 2-arylphenoxyacetaldehyde inhibitor derived by the Substrate Activity Screening (SAS) method'''
+===The structure of cathepsin S with a novel 2-arylphenoxyacetaldehyde inhibitor derived by the Substrate Activity Screening (SAS) method===
-==Overview==
+<!--
-The substrate activity screening (SAS) method, a substrate-based fragment identification and optimization method for the development of enzyme inhibitors, was previously applied to cathepsin S to obtain a novel (2-arylphenoxy)acetaldehyde inhibitor, 2, with a 0.49 microM Ki value (Wood, W. J. L.; Patterson, A. W.; Tsuruoka, H.; Jain, R. K.; Ellman, J. A. J. Am. Chem. Soc. 2005, 127, 15521-15527). In this paper we disclose the X-ray structure of a complex between cathepsin S and inhibitor 2 which reveals an unprecedented binding mode. On the basis of this structure, additional 2-biaryloxy substrates with greatly increased cleavage efficiency were designed. Conversion of the optimized substrates to the corresponding aldehyde inhibitors yielded a low molecular weight (304 Daltons) and potent (9.6 nM) cathepsin S inhibitor that showed from 100- to &gt;1000-fold selectivity relative to cathepsins B, L, and K.
+The line below this paragraph, {{ABSTRACT_PUBMED_17469812}}, adds the Publication Abstract to the page
+(as it appears on PubMed at http://www.pubmed.gov), where 17469812 is the PubMed ID number.
+-->
+{{ABSTRACT_PUBMED_17469812}}
 ==About this Structure==
@@ Line 32: / Line 36: @@
 [[Category: Nonpeptidic]]
 [[Category: Substrate activity screening]]
-''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 11:22:01 2008''
+''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 03:03:21 2008''